![Pierre Gianello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Gianello
Direttore/Membro del Consiglio presso
NYXOAH SA
Patrimonio netto: 37 270 $ in data 30/06/2026
Profilo
Pierre Gianello is the founder of SYnAbs SA, which was founded in 2015.
He is currently a Director at Brussels Life Science Incubator SA and a Director at Pig For Life SA. He is also a Non-Executive Director at Nyxoah SA since 2018.
Dr. Gianello's former positions include being a Director at BruCells NV and Fetus For Life.
He was also a Professor at Katholieke Universiteit Leuven from 1997 to 2011.
Dr. Gianello holds a doctorate degree from Université Catholique de Louvain.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NYXOAH SA 0,02% | 01/03/2026 | 21.560 ( 0,02% ) | 37 270 $ | 30/06/2026 |
Posizioni attive di Pierre Gianello
| Società | Posizione | Inizio |
|---|---|---|
| NYXOAH SA | Direttore/Membro del Consiglio | 27/03/2018 |
Brussels Life Science Incubator SA
 Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Direttore/Membro del Consiglio | - |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Pierre Gianello
| Società | Posizione | Fine |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2011 |
Fetus For Life | Direttore/Membro del Consiglio | - |
SynAbs SA
 SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Fondatore | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Direttore/Membro del Consiglio | - |
Formazione di Pierre Gianello
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
49
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brussels Life Science Incubator SA
Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Finance |
Nyxoah SA
 Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
SynAbs SA
SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Health Technology |
Pig For Life SA
Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Process Industries |
Fetus For Life |
